Understanding Paracoccidioidomycosis and Its Effects on the Body

Written by Medicover Team and Medically Reviewed by Dr Alla Bhagyaraj , Pulmonologists

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Paracoccidioidomycosis (PCM) is a systemic fungal infection caused by Paracoccidioides species, primarily Paracoccidioides brasiliensis and Paracoccidioides lutzii.

It is prevalent in rural areas of Latin America, particularly where agricultural activities occur. Also known as South American blastomycosis, PCM is a chronic granulomatous disease that primarily affects the lungs but can spread to other organs, including the skin, mucous membranes, lymph nodes, and adrenal glands.

It is more common in men, particularly in the chronic adult form, possibly because estrogen may inhibit the transformation of the fungus into its pathogenic yeast form. Understanding the symptoms, causes, diagnosis, and treatment options is essential for managing this potentially serious disease.

What are the Types of Paracoccidioidomycosis?

Paracoccidioidomycosis is a systemic fungal infection caused by Paracoccidioides species. It generally presents in two main clinical forms, which differ in their typical age groups, organs affected, and rate of progression.

Acute/Subacute (Juvenile) Form: This form primarily affects children, adolescents, and young adults. It progresses rapidly and commonly involves the lymphatic system, liver, spleen, and bone marrow. Symptoms include prolonged fever, weight loss, enlarged lymph nodes (lymphadenopathy), hepatosplenomegaly, anemia, and general weakness. Prompt diagnosis and treatment are important because this form can progress quickly.
Chronic (Adult) Form: The most common form, typically seen in adult males, especially those with occupational exposure to soil. It develops slowly and mainly affects the lungs but may also involve the skin, mucous membranes, lymph nodes, and adrenal glands. Symptoms include chronic cough, shortness of breath, chest pain, oral or nasal lesions, and fatigue. Without treatment, the disease can persist and cause progressive organ damage.

Understanding the clinical form of paracoccidioidomycosis helps healthcare professionals determine the appropriate diagnostic evaluation and antifungal treatment.

What are the Causes of Paracoccidioidomycosis?

Paracoccidioidomycosis is caused by infection with dimorphic fungi of the genus Paracoccidioides. Infection usually occurs when a person inhales fungal particles from contaminated soil or dust in endemic areas.

Etiological Agents

Paracoccidioidomycosis is caused primarily by the dimorphic fungi Paracoccidioides brasiliensis and Paracoccidioides lutzii. These fungi exist in a mould form in the environment and can convert into a yeast form after entering the human body.

Infection occurs mainly through the inhalation of airborne fungal particles present in contaminated soil. Once inhaled, the fungi can establish infection in the lungs and may spread to other organs through the bloodstream or lymphatic system.

What are the Symptoms of Paracoccidioidomycosis?

Paracoccidioidomycosis can cause different symptoms depending on the clinical form and organs involved. The lungs, lymph nodes, skin, and mucous membranes are commonly affected, while disseminated disease can involve other organs.

Acute/Subacute (Juvenile) Form

The acute or subacute form, also known as juvenile-type paracoccidioidomycosis, is less common and primarily affects children, adolescents, and young adults. It progresses rapidly and commonly involves the reticuloendothelial system.

Fever: Persistent or intermittent fever
Lymphadenopathy: Enlarged lymph nodes, especially in the cervical, axillary, and inguinal regions
Hepatosplenomegaly: Enlargement of the liver and spleen
Skin and mucosal lesions: Painful ulcerative lesions affecting the skin or oral mucosa
Weight loss and fatigue: General weakness and reduced appetite
Anemia: May occur with significant systemic or bone marrow involvement

Chronic (Adult) Form

The chronic form, also known as adult-type paracoccidioidomycosis, is more common and typically affects adults, particularly males. It develops gradually and primarily involves the lungs.

Respiratory symptoms: Chronic cough, sputum production, and shortness of breath (dyspnea)
Chest pain: Discomfort associated with lung involvement
Weight loss: Progressive weight loss and reduced appetite
Mucosal lesions: Painful ulcerations in the mouth, nose, gums, or throat
Skin lesions: Verrucous, nodular, or ulcerative skin lesions
Fatigue: Persistent tiredness and reduced physical capacity

Symptoms may worsen without treatment and can lead to complications such as chronic lung damage, fibrosis, adrenal involvement, or spread to other organs. Early recognition and treatment are important to reduce these risks.

When to See a Doctor?

Consult a pulmonologist if persistent respiratory, systemic, skin, or mucosal symptoms occur, particularly if you have lived or worked in an area where paracoccidioidomycosis is common.

Chronic cough, shortness of breath, or chest discomfort
Unexplained weight loss, fever, or persistent fatigue
Skin or mouth lesions that do not heal

Get medical help immediately if:

Severe breathing difficulty or rapidly worsening respiratory symptoms
Rapid weight loss, severe weakness, or persistent high fever
Signs of widespread infection or significant organ involvement

These symptoms may indicate severe or disseminated paracoccidioidomycosis and require prompt medical evaluation.

Find Pulmonologists for Paracoccidioidomycosis Treatment Near You

How Is Paracoccidioidomycosis Diagnosed?

Diagnosing paracoccidioidomycosis involves evaluating the patient's symptoms, exposure history, and clinical findings, followed by laboratory testing to identify the fungus and assess the extent of disease.

Clinical Evaluation

Diagnosis begins with a detailed medical history and physical examination. A history of living or working in an endemic region, particularly with regular soil exposure, can raise suspicion when compatible respiratory or systemic symptoms are present.

Laboratory Tests

Microscopy and Culture: Direct microscopy of clinical specimens such as sputum, pus, or tissue samples can identify the characteristic yeast forms of Paracoccidioides. Fungal culture can help confirm the diagnosis.
Serological Tests: Detection of antibodies against Paracoccidioides antigens can support the diagnosis and may be useful for monitoring treatment response.
Molecular Methods: Polymerase chain reaction (PCR) and other molecular methods may detect fungal DNA in selected clinical samples, although availability varies.
Imaging: Chest X-rays or CT scans may be used to evaluate lung involvement and identify complications or disease spread.

Combining clinical findings with laboratory and imaging results helps confirm paracoccidioidomycosis and determine the extent of organ involvement.

What are the Treatment Options for Paracoccidioidomycosis?

Treatment of paracoccidioidomycosis primarily involves antifungal medicines. The choice of treatment depends on the severity and clinical form of the disease, the organs involved, and the patient's overall health.

Antifungal Therapy

Antifungal treatment is usually prolonged and requires medical supervision, with follow-up needed to assess clinical improvement and monitor for complications or recurrence.

Itraconazole: Commonly used as a preferred oral treatment for mild to moderate disease and may be continued for several months based on clinical response.
Amphotericin B: Used for severe, rapidly progressive, or disseminated disease, particularly when oral therapy is not appropriate. Treatment may be followed by an oral antifungal after clinical improvement.
Trimethoprim-Sulfamethoxazole (TMP-SMX): An alternative oral treatment that may be used in selected patients, although therapy generally requires a longer duration.

Supportive Care

Nutritional Support: Patients with significant weight loss may require nutritional assessment and supplementation.
Management of Complications: Complications such as respiratory impairment, adrenal insufficiency, or secondary infections require appropriate supportive treatment.

Regular follow-up is important because treatment may need to continue for an extended period, and clinical, laboratory, and imaging findings can help determine when therapy can be safely discontinued.

Your health is everything - prioritize your well-being today.

Consult Paracoccidioidomycosis Doctors Today

What are the Risk Factors of Paracoccidioidomycosis?

Several environmental, occupational, and individual factors can increase the likelihood of developing paracoccidioidomycosis, particularly in people living or working in endemic regions.

Occupational exposure: Farming, agriculture, mining, and construction work involving soil disturbance can increase exposure to fungal particles.
Geographical location: Living in or regularly visiting endemic areas of Latin America, particularly Brazil, Colombia, Venezuela, and other affected regions, increases exposure risk.
Immunosuppression: People with weakened immune systems may be more likely to develop severe or disseminated disease.
Smoking and alcohol use: These factors are associated with a higher risk of chronic pulmonary disease and may contribute to more severe illness.
Male sex: The chronic adult form occurs predominantly in men, potentially because estrogen has protective effects against fungal transformation and infection.
Rural living conditions: Living in rural areas may increase exposure to soil and environmental fungal particles.

Recognizing these risk factors can help healthcare professionals identify people who may require earlier evaluation when compatible symptoms develop.

How Can Paracoccidioidomycosis Be Prevented?

There is no specific vaccine that prevents paracoccidioidomycosis. Prevention focuses mainly on reducing exposure to soil and dust that may contain Paracoccidioides in endemic areas.

Use Protective Equipment: Wear appropriate masks and protective clothing during activities that disturb soil or generate dust.
Reduce Dust Exposure: Use measures that limit dust and soil aerosolization during agricultural, construction, and other soil-disturbing activities.
Health Education: People living or working in endemic regions should understand occupational risks and seek medical evaluation for persistent respiratory or systemic symptoms.
Avoid Smoking: Avoiding tobacco use may reduce the risk of chronic pulmonary complications and support overall lung health.

Because environmental exposure is difficult to eliminate completely in endemic regions, awareness of occupational risks and early medical evaluation remain important preventive strategies.

Frequently Asked Questions

1. How long does paracoccidioidomycosis last?

Paracoccidioidomycosis can last months to years. With appropriate antifungal treatment, symptoms usually improve gradually, but chronic cases may require long-term therapy and follow-up.

2. What is the drug of choice for Paracoccidioides infection?

Itraconazole is commonly used for mild to moderate paracoccidioidomycosis. Severe cases may require amphotericin B initially, followed by oral antifungal treatment.

3. Can paracoccidioidomycosis affect organs other than the lungs?

Yes. The infection can spread beyond the lungs and affect the lymph nodes, skin, mouth, adrenal glands, and other organs, particularly in disseminated disease.

4. Is paracoccidioidomycosis contagious?

No. Paracoccidioidomycosis is not spread from person to person. It is usually acquired by inhaling fungal spores from contaminated soil in endemic areas of Latin America.

5. Can paracoccidioidomycosis cause permanent damage?

Yes. Severe or untreated disease can cause lung scarring, chronic breathing problems, adrenal damage, and other long-term complications. Early diagnosis and antifungal treatment can reduce the risk of permanent damage.